Live from the NIH registry
Studies recruiting near Santa Barbara right now
Top 25 of 97 recruiting studies, sorted by proximity — each links to its official registry page
Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)
Parkinson Disease
EARLY/Phase 1
Interventional 50 participants sought
Equilibrium Physical Therapy — Ventura, California (26.5 mi)
· Sponsor: California State University, Northridge
Stroke Thrombectomy and Aneurysm Registry
Stroke, Thromboses, Intracranial
N/A
Observational 40,000 participants sought
Cottage Health Research Institute — Santa Barbara, California (1.4 mi)
· Sponsor: Medical University of South Carolina
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
The CONFORM Pivotal Trial
Atrial Fibrillation, Stroke
N/A
Interventional 1,600 participants sought
Community Memorial Hospital Ventura — Ventura, California (26.5 mi)
· Sponsor: Conformal Medical, Inc
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Phase 3
Interventional 284 participants sought
Adverum Clinical Site 175 — Santa Barbara, California (1.4 mi)
· Sponsor: Adverum Biotechnologies, Inc.
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy
Phase 2
Interventional 100 participants sought
California Retina Consultants- Santa Barbara — Santa Barbara, California (1.4 mi)
· Sponsor: Vantage Biosciences Ltd
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast Cancer, Locally Advanced Breast Cancer
Phase 3
Interventional 1,000 participants sought
Clinical Trial Site — Santa Barbara, California (1.4 mi)
· Sponsor: Olema Pharmaceuticals, Inc.
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ovarian Neoplasms, Fallopian Tube Neoplasms
Phase 3
Interventional 1,630 participants sought
Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: Eli Lilly and Company
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: NRG Oncology
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: Amgen
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Santa Barbara, California (1.4 mi)
· Sponsor: DalCor Pharmaceuticals
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Phase 3
Interventional 4,220 participants sought
Sansum Clinic — Solvang, California (26.4 mi)
· Sponsor: Stemline Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS
ALS (Amyotrophic Lateral Sclerosis)
N/A
Interventional 10 participants sought
Cognixion — Santa Barbara, California (1.4 mi)
· Sponsor: Cognixion
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Pulmonary Hypertension, Interstitial Lung Disease
Phase 3
Interventional 344 participants sought
USA001 — Santa Barbara, California (1.4 mi)
· Sponsor: Insmed Incorporated
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
UCLA Montecito Primary & Specialty Care — Montecito, California (5.1 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: NRG Oncology
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Epithelial Ovarian Cancer, Primary Peritoneal
Phase 2
Interventional 230 participants sought
SCRI - Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: TORL Biotherapeutics, LLC
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Multiple Myeloma
Phase 1
Interventional 134 participants sought
Sansum Clinic- Ridley-Tree Cancer Center — Santa Barbara, California (1.4 mi)
· Sponsor: Oncotherapeutics
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Aortic Stenosis, Coronary Artery Disease
N/A
Interventional 4,000 participants sought
Santa Barbara Cottage Hospital — Santa Barbara, California (1.4 mi)
· Sponsor: University of British Columbia
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 272 participants sought
California Retina Consultants — Santa Barbara, California (1.4 mi)
· Sponsor: Novartis Pharmaceuticals
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Sansum Clinic — Santa Barbara, California (1.4 mi)
· Sponsor: SCRI Development Innovations, LLC
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Venous Thromboembolism, Metastatic Pancreatic Cancer
Phase 3
Interventional 480 participants sought
Ventura Clinical Trials — Ventura, California (26.5 mi)
· Sponsor: Quercis Pharma AG
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Santa Barbara Cottage Hospital — Santa Barbara, California (1.4 mi)
· Sponsor: National Cancer Institute (NCI)